Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lifecore Biomedical (LFCR) Beginning Cash Balance: 2009-2025

Historic Beginning Cash Balance for Lifecore Biomedical (LFCR) over the last 17 years, with May 2025 value amounting to $8.5 million.

  • Lifecore Biomedical's Beginning Cash Balance rose 76.28% to $5.4 million in Q2 2025 from the same period last year, while for May 2025 it was $8.5 million, marking a year-over-year decrease of 55.68%. This contributed to the annual value of $8.5 million for FY2025, which is 55.68% down from last year.
  • As of FY2025, Lifecore Biomedical's Beginning Cash Balance stood at $8.5 million, which was down 55.68% from $19.1 million recorded in FY2024.
  • Lifecore Biomedical's 5-year Beginning Cash Balance high stood at $19.1 million for FY2024, and its period low was $21,000 during FY2021.
  • Its 3-year average for Beginning Cash Balance is $9.7 million, with a median of $8.5 million in 2025.
  • Its Beginning Cash Balance has fluctuated over the past 5 years, first crashed by 98.35% in 2021, then soared by 2,961.90% in 2022.
  • Yearly analysis of 5 years shows Lifecore Biomedical's Beginning Cash Balance stood at $21,000 in 2021, then surged by 2,961.90% to $643,000 in 2022, then skyrocketed by 155.52% to $1.6 million in 2023, then skyrocketed by 1,061.96% to $19.1 million in 2024, then tumbled by 55.68% to $8.5 million in 2025.